Use access key #2 to skip to page content.
$61.46 6.94 (12.73%)
10/13/2008 4:00 PM

Celgene Corp (CELG)

CAPS Rating:
****

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

View All Commentary (CELG)

Recs

0

Avatar ypcheng (87.50) Submitted: 2/25/08 10:34 AM : Outperform Start Price: $56.09 CELG Score: 9.74

In light of the approval of Avastin by FDA to Genetech, I believe this company will gets its approvals of its rich pipeline and its stock should go up.

Report this Post Replies: 0 | Reply

Featured Broker Partners